|Articles|July 30, 2015

ICON Forms Clinical Development Partnership with Mereo BioPharma

Contract research organization ICON plc announced a partnership with Mereo BioPharma Group, a specialty biopharmaceutical company.

Contract research organization ICON plc announced a partnership with Mereo BioPharma Group, a specialty biopharmaceutical company. Under this partnership, ICON will be the sole provider of clinical development services to Mereo.
 Mereo is a new UK company that is focused on acquiring, developing and commercializing medicines that are targeted at rare and specialist disease areas. The company’s initial portfolio consists of clinical-stage products acquired from Novartis and are targeted at brittle bone syndrome, acute exacerbations of chronic obstructive pulmonary disease and hypogonadotropic hypogonadism.
 
 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.